Telepsychology Use Up 12-Fold in the US During Pandemic
However, adoption of telepsychology has varied according to individual and practice characteristics
Technology
Intravaginal Home-Use Device Cleared for Stress Urinary Incontinence
Flyte is an in-home treatment designed to strengthen and treat weakened pelvic floor muscles.
Protecting Practices From Ransomware
Hackers have penetrated healthcare providers’ computer systems to encrypt information and demand money for its release.
EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening
EyeArt is the first FDA-cleared AI technology for autonomous detection of more than mild diabetic retinopathy and vision-threatening diabetic retinopathy.
Telemedicine Use Explodes During COVID-19 Pandemic
Two experts spdoke with HD Live! about telemedicine’s growth, best practices, outlook for the future
App Approval Provides Flexibility for Patients Treated With Abbott’s Neuromodulation Devices
The FDA has approved an iOS-compatible app designed to work in tandem with Abbott’s neuromodulation technologies. The Company hopes the app will eliminate the need for patients to carry a separate programmer device and improve remote care.
FDA Approves DBS Neurostimulation System With Brain Signal Tracking
The FDA has approved the Percept™ PC Deep Brain Stimulation (DBS) system (Medtronic) with BrainSense™ technology for neurological disorders.
FDA Clears Video Game-Based Therapy for Pediatric ADHD
The FDA has cleared EndeavorRxTM (AKL-T01; Akili Interactive) for use as a prescription-only video game-based digital therapeutic to improve attention function in pediatric patients aged 8-12 years with primarily inattentive or combined-type ADHD.
FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes
The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.
Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler
The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a corticosteroid and long-acting beta-2 agonist indicated for the treatment of asthma and COPD. The Propeller platform includes a sensor that is attached to the inhaler. The sensor delivers insights on…
